tradmap

THC Tenet Healthcare Corp

$268.54 -1.64%

Data as of close

Healthcare · Services-General Medical & Surgical Hospitals, Nec

Tenet Healthcare Corp (THC) is a healthcare company in the Services-General Medical & Surgical Hospitals, Nec industry, with a market capitalization of $21.4 billion. Shares last traded at $268.54, 5.1% below their 52-week high. Over the past year the stock is up 28.8%. THC trades at a price-to-earnings ratio of 5.60, below the Services-General Medical & Surgical Hospitals, Nec median of 8.23. Net profit margin is 17.2%, above the peer median of 4.8%. Revenue grew 3.1% year over year.

Market Cap
$21.4B
Shares Out
79.6M
EPS (TTM)
$34.48
P/E (TTM)*
5.60
P/S Ratio
0.96
P/B Ratio
3.93
Dividend / Share
—
Dividend Yield
—
52-Week High
$282.83
52-Week Low
$157.72
Volume (venue)
81,031
Avg Vol (3m, venue)
43,609.127

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
-0.16%
1M
+3.90%
3M
+6.05%
6M
+44.89%
YTD
+35.13%
1Y
+28.81%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
52.54
SMA (50)
$264.63
SMA (200)
$220.68
Price vs SMA50
+1.48%
Price vs SMA200
+21.69%
ATR (14)
$9.12

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$22.2B
Net Income
$3.8B
Gross Margin
—
Operating Margin
24.4%
Net Margin
17.2%
Return on Equity
70.1%
Return on Assets
12.1%
Current Ratio
1.58
Debt / Equity
0.76
Revenue Growth (YoY)
+3.1%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-09-30. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q3 2026 $12.41 2026-10-29
Q2 2026 $9.84 2026-07-29
Q1 2026 $8.01 2026-04-30
Q4 2025 (derived) $4.22 2026-02-17
FY 2025 $15.49 2026-02-17
Q3 2025 $3.86 2025-10-28

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Services-General Medical & Surgical Hospitals, Nec peers

THC vs 6 industry peers (Services-General Medical & Surgical Hospitals, Nec), by market cap. Data as of close

P/E vs peers
5.60 / 8.23 med
-32% discount
P/S vs peers
0.96 / 0.74 med
+30% premium
Net margin vs peers
17.2% / 4.8% med
above median
1–6 of 6
HCAHCA Healthcare$97.7B14.421.248.6%-1.15%
THCTenet Healthcare Corp$21.4B5.600.9617.2%-1.64%
UHSUniversal Health Services$10.6B6.980.598.4%+2.67%
SGRYSurgery Partners, Inc.$3.0B—0.90-2.6%-0.26%
ARDTArdent Health, Inc.$1.7B21.150.261.2%-2.41%
CYHCommunity Health Systems Inc$296M8.230.030.3%-12.13%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.